Lilly gave more than $700 million in strategic charitable contributions in 2012 to help people living in impoverished communities, patients facing financial hardship, and families struggling to recover from natural disasters. This was an increase over the previous year, largely driven by an 18-percent jump in the number of people served through our U.S. patient-assistance programs.
How does our total giving break down? We donated products valued at more than $645 million through our U.S. patient-assistance programs, global health programs and disaster-relief efforts. These efforts tie back to our vision to improve global health in the 21st century. We believe we will have the greatest impact by linking our corporate responsibility efforts to our business operations and expertise.
Our cash and in-kind services totaled more than $55 million to help strengthen education, reduce hunger, and improve health and human services in our communities.
Highlights from some of our key programs:
- U.S. patient-assistance programs: In 2012, more than 300,000 people received help paying for their Lilly medicines—including mental health drugs, insulin, and many others.
- Lilly Global Giving: Since the launch of Lilly Global Giving in 2011, employees helped raise nearly $860,000 to support hundreds of global projects for people in need.
- Connecting Hearts Abroad: Nearly 220 employees from 44 countries volunteered as ambassadors in impoverished communities in 11 countries in 2012.
- Global Day of Service: More than 20,000 employees in 40 countries volunteered last October in their local communities during the fifth Lilly Global Day of Service. (See video for one powerful example.)
Lilly oncology employees help bring a mother and daughter's inspirational artwork to life on Global Day of Service.
Signature global health programs:
- The Lilly Non-Communicable Diseases (NCD) Partnership– Committed $30 million over five years (2012-2016) to fight the rising burden of chronic diseases, with a focus on diabetes in impoverished communities in Brazil, India, Mexico, and South Africa.
- The Lilly Multi-Drug Resistant Tuberculosis (MDR-TB) Partnership – Pledged $30 million over five years (2012-2016) to improve health-care provider training and access to quality assured second-line medicines in China, India, Russia, and South Africa.
But our corporate giving is more than numbers in a spreadsheet. These programs directly touch people’s lives. For example, one woman said her mother had faithfully taken the Lilly medicine she received through our patient assistance program, which she said helped her mom live to her 100th birthday. With the letter came an invitation to a birthday party!
It’s example like this – and many others – that constantly remind us why we do what we do.